Puig’s Expansion Strategy: A Year of Bold Moves

In 2024, Puig, the Spanish fashion and beauty powerhouse [[3]], embarked on an ambitious expansion strategy, marked by significant acquisitions and strategic investments within the beauty industry. While the acquisition of German cosmetics brand Dr. Barbara Sturm provided an initial splash, the company’s most substantial financial commitments were directed towards increasing its stakes in Byredo and charlotte Tilbury.

strategic Acquisitions: Byredo and Charlotte Tilbury

Puig’s approach to corporate acquisitions typically involves a phased strategy.Initially, a majority stake is secured, followed by subsequent acquisitions of remaining shares over the following years. this approach was evident in their investments in both Byredo and Charlotte Tilbury,representing the Catalan company’s most significant financial undertakings.

Charlotte Tilbury: A Multi-phased Acquisition

The acquisition of Charlotte Tilbury was executed in two distinct phases. The initial phase, coinciding with Puig’s IPO in March, involved a substantial outlay of €366 million in cash, coupled with €243 million through the issuance of new shares. this secured 73.1% of the cosmetic firm from Prado Investments, with BDT Capital Partners retaining a 26.3% stake. Subsequently, Puig directly acquired an additional 5.4% of the British group’s capital for €214.8 million, bringing their total control to 78.5%. An agreement was also reached in December to extend the purchase option calendar, initially set to expire in 2025, to the end of 2030. this extension, combined with projected growth indicators, positively impacted puig’s assets by €197.5 million.

The total cash outlay for Charlotte Tilbury amounted to €580 million,in addition to the share remuneration for BDT Capital Partners.

Byredo: Completing the Acquisition

Prior to increasing its stake in Charlotte Tilbury, Puig finalized its acquisition of the Swedish fragrance brand Byredo, initially acquired in 2022. Puig increased its ownership from 77% to 100% through two transactions: acquiring 20% from Manzanita for €214 million and purchasing the remaining 3% held by founder Ben Gorham for €16 million in cash and an additional €16 million in Class B shares. The total cash investment in Byredo reached €230 million.

financial Implications and Debt Financing

The combined cash investment in Byredo and charlotte Tilbury totaled €810 million. When factoring in the €291 million spent on acquiring Dr. Barbara Sturm, Puig’s total investment in acquisitions for 2024 reached approximately €1.1 billion.

Securing Capital Through Debt

To finance these significant transactions, particularly the acquisitions of Byredo and Charlotte tilbury, Puig secured €680 million from its primary banking partners through revolving credit facilities.

According to the IPO prospectus, Puig established three revolving credit lines in February, each worth €150 million, with maturities ranging from one to two years, with the option to extend for an additional 24 months. These lines of credit carried interest rates between Euribor +0.8% and euribor +0.9%. An additional €30 million credit line was secured a month later, expiring in March 2026, with an interest rate of Euribor +0.49%.

In April,further debt operations were finalized,involving €200 million distributed across three revolving credit lines with two-year terms,extendable by an additional two years. The interest rates for these lines ranged from 0.5% for a €50 million line to 0.9% for the remaining €75 million lines.

Financial Performance and Future Outlook

Despite the substantial investment in acquisitions, Puig demonstrated strong financial performance in 2024. The company increased its net profit to €530.6 million, a 14% increase, driven in part by the accounting revaluation of purchase options related to Charlotte Tilbury. Sales also saw significant growth,reaching €4.79 billion, an 11.3% increase.

Puig’s strategic investments in high-growth beauty brands like Charlotte Tilbury and Byredo position the company for continued success in the competitive beauty market.